Titomirov: Informax Seeks to Grow Business Through Collaborations | GenomeWeb

NEW YORK, Feb 6 – Informax's business strategy entails looking beyond off-the-shelf sales of its software toward developing hands-on collaborations, such as the partnership the company forged with Axcell Biosciences, Informax CEO Alex Titomirov said Tuesday.

“We’d like to have collaborations and technologies that map [bioinformatics] onto development,” Titomirov told GenomeWeb following a media seminar in New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.